Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma

Gynecologic Oncology

Volumn 124, Issue 3, 2012, Pages 558-562

  Leitao Jr , Mario M ^a   Hensley, Martee L ^a   Barakat, Richard R ^a   Aghajanian, Carol ^a   Gardner, Ginger J ^a   Jewell, Elizabeth L ^a   O'Cearbhaill, Roisin ^a   Soslow, Robert A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Estrogen receptor; Outcome; Progesterone receptor; Uterine leiomyosarcoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE LEIOMYOSARCOMA; UTERUS SARCOMA;

ADULT; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 84856752432     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.11.009     Document Type: Article

References (22)

1. B.L. Harlow, N.S. Weiss, and S. Lofton The epidemiology of sarcomas of the uterus J Natl Cancer Inst 76 1986 399 402
2. C. Zaloudek, and H.J. Norris Mesenchymal tumors of the uterus R.J. Kurman, Blaustein's pathology of the female genital tract 1994 Soringer-Verlag New York 487 528
3. M. Leitao Jr., Y. Sonoda, M.F. Brennan, R.R. Barakat, and D.S. Chi Incidence of lymph node and ovarian metastases in uterine leiomyosarcoma Gynecol Oncol 91 2003 209 212
4. A. Berchuck, S.C. Rubin, W.J. Hoskins, P.E. Saigo, V.K. Pierce, and J.L. Lewis Jr. Treatment of uterine leiomyosarcoma Obstet Gynecol 71 1988 845 850
5. O. Zivanovic, M.M. Leitao, A. Iasonos, L.M. Jacks, Q. Zhou, and N.R. Abu-Rustum Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems J Clin Oncol 27 2009 2066 2072
6. E. Veras, O. Zivanovic, L. Jacks, D. Chiappetta, M. Hensley, and R. Soslow "Low-grade leiomyosarcoma" and late recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas Am J Surg Pathol 35 2011 1626 1637
7. K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathologic parameters Anticancer Res 23 2003 729 732
8. K. Mittal, and R.I. Demopoulos MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors Hum Pathol 32 2001 984 987
9. J.T. Soper, K.S. McCarty Jr., W. Hinshaw, W.T. Creasman, K.S. McCarty Sr., and D.L. Clarke-Pearson Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas Am J Obstet Gynecol 150 1984 342 348
10. G.P. Sutton, F.B. Stehman, H. Michael, P.C. Young, and C.E. Ehrlich Estrogen and progesterone receptors in uterine sarcomas Obstet Gynecol 68 1986 709 714
11. K. Wade, M.A. Quinn, I. Hammond, K. Williams, and M. Cauchi Uterine sarcoma: steroid receptors and response to hormonal therapy Gynecol Oncol 39 1990 364 367
12. Y. Zhai, Y. Kobayashi, A. Mori, A. Orii, T. Nikaido, and I. Konishi Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas Int J Gynecol Pathol 18 1999 20 28
13. T. Uchida, K. Nakakawaji, J. Sakamoto, H. Kojima, H. Murakami, and J. Kato The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case Surg Today 26 1996 138 141
14. E.G. Silva, C.S. Tornos, and M. Follen-Mitchell Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen Int J Gynecol Pathol 13 1994 248 258
15. M.M. Leitao, R.A. Soslow, D. Nonaka, A.B. Olshen, C. Aghajanian, and P. Sabbatini Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 101 2004 1455 1462
16. S.W. Bell, R.L. Kempson, and M.R. Hendrickson Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases Am J Surg Pathol 18 1994 535 558
17. FIGO staging for uterine sarcomas Int J Gynaecol Obstet 104 2009 179
18. G.A. Omura, J.A. Blessing, F. Major, S. Lifshitz, C.E. Ehrlich, and C. Mangan A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study J Clin Oncol 3 1985 1240 1245
19. N.S. Reed, C. Mangioni, H. Malmstrom, G. Scarfone, A. Poveda, and S. Pecorelli Phase III randomized study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 44 2008 808 818
20. R. Koivisto-KOrander, A. Leminen, and O. Heikinheimo Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma Obstet Gynecol 109 2007 512 514
21. R. O'Cearbhaill, Q. Zhou, A. Iasonos, R.A. Soslow, M.M. Leitao, and C. Aghajanian Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors Gynecol Oncol 116 2010 424 429
22. NCT00414076. Letrozole versus observation in patients with newly diagnosed uterine leiomyosarcoma http://www.clinicaltrials.gov/ct2/show/ NCT00414076?term=uterine+leiomyosarcoma&rank=1 (accessed 7/15/11)